Point72 »

Genes shares owned by Point72

Quarter-by-quarter ownership of Genes (GCO) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $45k 1.6k 27.17
2024-06-30 $2.5k 95 25.86
2024-03-31 $6.9k 245 28.14

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Genes

Pzena Investment Management
BlackRock
BlackRock
Alliancebernstein
Dimensional Fund Advisors
Vanguard Group
D. E. Shaw & Co
Acadian Asset Management
Marshall Wace
State Street Corporation
Arrowstreet Capital, Limited Partnership
Jpmorgan Chase & Co
Geode Capital Management
Charles Schwab Investment Management
American Century Companies

View all funds holding Genes